000			03985nam a22003855i 4500
001			234680
003			ES-VaUE
005			20221220020618.0
007			cr nn 008mamaa
008			160329s2016 xxu| s |||| 0|eng d
020			_a9781493933235
024	7		_a10.1007/978-1-4939-3323-5 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
245	1	0	_aAntibiotic Pharmacodynamics _cedited by John C. Rotschafer, David R. Andes, Keith A. Rodvold.
250			_a1st edition 2016
264		1	_aNew York, NY _bSpringer International Publishing _c2016
300			_a1 recurso en línea (XI, 666 páginas) _b75 ilustraciones, 2 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aMethods in Pharmacology and Toxicology _x1940-6053
505	0		_aGeneral Concepts of Pharmacodynamics for Anti-Infective Agents -- In Vitro Pharmacodynamic Models to Evaluate Anti-Infective Pharmacodynamics -- Animal Models to Evaluate Anti-Infective Pharmacodynamics -- Pharmacodynamic Issues in Antibiotic Combinations -- Methodologies for Protein Binding Determination in Anti-Infective Agents -- Evaluation of Exposure-Response Relationships Using Clinical Data: Basic Concepts and Applications -- Toxicokinetics and Toxicodynamics of Anti-Infective Agents -- Pharmacodynamics of Fluoroquinolones -- Aminoglycoside Pharmacodynamics -- Polymyxin Pharmacokinetics and Pharmacodynamics -- Vancomycin Pharmacodynamics: Optimal vs. Controversial.- Pharmacodynamics of Lipoglycopeptides.- Pharmacodynamics of Daptomycin.- Newer Glycolipopeptides-Lipopeptides in Pharmacodynamics -- Pharmacodynamics of Macrolides, Azalides, and Ketolides -- Antifungal Pharmacokinetics and Pharmacodynamics -- Pharmacokinetics and Pharmacodynamics of the Tuberculosis Drugs -- Pharmacodynamics of Antimalarial Agents -- Pharmacodynamics of Antiviral Agents -- Pharmacodynamics of Antiretroviral Agents -- Implementing a Continuous or Prolonged Infusion Beta-Lactam Program in the Hospital Setting -- Pharmacodynamic Considerations in Critically Ill Patients -- Pharmacodynamic Considerations and Special Populations: Pediatrics -- Pharmacodynamics and Obesity -- Drug Development Process and Regulatory Science -- Antibiotic Stewardship and Applications of Pharmacodynamics.
520			_aThis text offers state of the art contributions written by world renown experts which provide an extensive background on specific classes of antibiotics and summarize our understanding as to how these antibiotics might be optimally used in a clinical situation.  The book explores pharmacodynamics methods for anti-infective agents, pharmacodynamics of antibacterial agents and non-antibacterial agents, as well as pharmacodynamic considerations and special populations. As part of the Methods in Pharmacology and Toxicology series, chapters include detailed insight and practical information for the lab. Comprehensive and cutting-edge, Antibiotic Pharmacodynamics serves as an ideal reference for scientists investigating advances in antibiotic pharmacodynamics now finding their way into the antibiotic development process used for licensing new antibiotics.
700	1		_aRotschafer, John C _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aAndes, David R _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aRodvold, Keith A _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9781493933211
776	0	8	_iPrinted edition: _z9781493933228
776	0	8	_iPrinted edition: _z9781493980192
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-4939-3323-5 _z(usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
988			_aSpringer_Protocols_2016
999			_c234680 _d234680